Cancer Research UK logo.
SearchDonate
  • Search

A trial of pembrolizumab with chemotherapy for cancer of the bile duct or gallbladder (KEYNOTE 966)

Overview

Cancer types:

Bile duct cancer, Biliary tree cancers, Gallbladder cancer, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at adding pembrolizumab to chemotherapy for cancer of the bile duct or gallbladder (the biliary tract).

It is for people whose cancer:

  • has spread into surrounding tissues and they can’t have surgery to remove it

  • has spread elsewhere in the body

This is advanced cancer.

Recruitment start: 28 July 2020

Recruitment end: 14 May 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr John Bridgewater

Supported by

Merck Sharp & Dohme

Last reviewed: 14 July 2021

CRUK internal database number: 16686

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.